F8Y-25454-57238 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-21
Dose 1 — Pfizer-BioNTech
2022-06-26
Registered in v-safe
2022-06-26
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-06-27
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-06-28
Health check-in — day 7, dose 1, dependent
Feeling: Good · None

Adult check-in
2022-07-05
Health check-in — day 14, dose 1, dependent
Feeling: Good

Adult check-in
2022-07-12
Health check-in — day 21, dose 1, dependent
Feeling: Good

Adult check-in
2022-07-19
Health check-in — day 28, dose 1, dependent
Feeling: Good

Adult check-in
2022-07-22
Dose 2 — Pfizer-BioNTech
2022-07-26
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-07-28
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2022-08-07
Health check-in — day 14, dose 2, dependent
Feeling: Good

Adult check-in
2022-08-19
Health check-in — day 28, dose 2, dependent
Feeling: Good

Adult check-in
2022-08-26
Health check-in — day 35, dose 2, dependent
Feeling: Good

Adult check-in
2022-09-02
Survey response — day 42, dose 2, dependent
MedDRA: Pyrexia, Respiratory tract congestion — Feeling: Fair

Free text: Fever, congestion

MedDRA releases: 2024-11 · check-in free text available
2022-10-21
Survey response — 3 months, dose 2, dependent
MedDRA: Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: RSV

MedDRA releases: 2024-11 · check-in free text available
2022-10-21
Report sent to call center — 3 months, dose 2, dependent
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-10-24
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-01-20
Survey response — 6 months, dose 2, dependent
MedDRA: Nasopharyngitis, Pyrexia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-01-20
Report sent to call center — 6 months, dose 2, dependent
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-01-23
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-21	Pfizer-BioNTech	No
2	2022-07-22	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-10-21	Successful 2022-10-24	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-01-20	Unsuccessful

Free text

Release 12 — day 42, dose 2, dependent

2022-09-02

Symptoms: Fever, congestion

Release 12 — 3 months, dose 2, dependent

2022-10-21

Symptoms: RSV

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release